Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Services-Home Health Care Services

Owens & Minor, Inc. to acquire Apria, Inc.

Announced Jan 10, 2022 · Closed Mar 29, 2022

Deal value$1.45BEV $1.62B
Premium26.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$37.50 per share

Transaction

Acquirer
Owens & Minor, Inc. (OMI)
Target
Apria, Inc.
Buyer type
Strategic
Offer price per share
$37.50
Enterprise value
$1.62B
Status
Closed Mar 29, 2022

Deal protections

Break fee (target pays)
$42.0M · 2.9%
Reverse fee (buyer pays)
—
Go-shop
No-shop
Financing
Committed · JPMorgan, Goldman Sachs

Advisors

To the acquirer
Evercore, JPMorgan
To the target
Goldman Sachs, Citigroup

Sector context · Healthcare

Comparable deals
33 in the prior 24 months
Premium
26.0% vs. 45.5% sector median
EV / Adj. EBITDA
Sector median 20.4x
Break fee
2.9% vs. 3.4% sector median

Timeline

  1. AnnouncedJan 10, 2022
  2. Proxy filedFeb 7, 2022
  3. Definitive proxyFeb 22, 2022
  4. Shareholder voteMar 24, 2022
  5. ClosedMar 29, 2022

Valuation · fairness opinions

Future share price$29.72$37.16
Discounted cash flow$31.74$43.99
Discounted cash flow$32.16$44.43
Premiums paid$32.29$37.73
Offer $37.50

Implied value per Apria, Inc. share by analysis, from Goldman Sachs · DCF discount rate 7.5%–9%.

Sources
  • 8-K (EX-99) · Jan 10, 2022
  • 8-K · Jan 10, 2022

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.